论文部分内容阅读
作者检查了73例不同发展阶段的肾小球肾炎患者血清和尿中的溶菌酶含量,并以5例健康者作对照。患者分3组,第一组45例,慢性肾小球肾炎肾功能不全Ⅱ—Ⅲ_b,第二组6例,同上但肾功能不全Ⅱ_a,第三组18例慢性肾小球肾炎急性发作但无肾功能不全,此组包括4例急性肾炎患者。健康对照者血清溶菌酶含量为8.60±0.275(单位为微克/毫升,下同)尿中则没有溶菌酶。第一组患者血清溶菌酶含量(31例平均34.60±1.86)和尿溶菌酶含量(12例平均29.57±3.46)都显著增高。第二组患者血清溶菌酶明显增加(4例平均32.75±3.019),尿中溶菌酶中等度增加(3例平均4.66±0.868)。第三组患者血清溶菌酶
The authors examined the serum and urinary lysozyme levels in 73 patients with glomerulonephritis at different stages of development and compared them to 5 healthy controls. Patients were divided into 3 groups, the first group of 45 cases, chronic renal glomerulonephritis II-III_b, the second group of 6 cases, supra, but renal insufficiency Ⅱ_a, the third group of 18 cases of acute exacerbation of chronic glomerulonephritis but no Renal insufficiency, this group includes 4 cases of acute nephritis patients. Healthy control serum lysozyme content of 8.60 ± 0.275 (in micrograms / ml, the same below) no lysozyme in urine. The first group of patients with serum lysozyme content (31 cases, an average of 34.60 ± 1.86) and urine lysozyme content (12 cases, an average of 29.57 ± 3.46) were significantly higher. Serum lysozyme was significantly increased in the second group (averaged, 32.75 ± 3.019 in 4 cases) and moderate increase in lysozyme in urine (averaged, 4.66 ± 0.868 in 3 cases). The third group of patients with serum lysozyme